What You Need to Know About the J&J Vaccine Blood Clot Risk [Updated]
by Beth Skwarecki on Vitals, shared by Joel Cunningha from Lifehacker on (#5GHF6)
At least six people out of over 6 million who have received the Johnson & Johnson/Janssen COVID vaccine have developed a rare type of blood clot. As a result, the FDA and CDC have announced a pause in the use of this vaccine. The pause is likely to last at least another week.